2021 Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Nicolaus Kröger Journal Leukemia.
2021 Special issues related to the diagnosis and management of acquired aplastic anemia in countries with restricted resources, a report on behalf of the Eastern Mediterranean blood and marrow transplantation (EMBMT) group and severe aplastic anemia working party of the European Society for blood and marrow transplantation (SAAWP of EBMT) Group Severe Aplastic Anaemia Working Party (SAAWP) Other society 1st listed author Raheel Iftikhar Journal Bone Marrow Transplant.
2021 Adding eltrombopag to immunosuppression: the importance of predicting outcome Group Severe Aplastic Anaemia Working Party (SAAWP) 1st listed author André Tichelli Journal Haematologica.
2021 Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Maria H Gilleece Journal Blood Cancer J.
2021 Feasibility and Outcomes of a Third Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Andreas Rank Journal Transplant Cell Ther.
2021 Systematic Reviews in Hematopoietic Cell Transplantation and Cellular Therapy: Considerations and Guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and Center for International Blood and Marrow Transplant Research Late Effects and Quality of Life Working Committee Group Transplant Complications Working Party (TCWP) Other society 1st listed author Akshay Sharma Journal Transplant Cell Ther.
2021 Outcomes of Unmanipulated Haploidentical Transplantation Using Post-Transplant Cyclophosphamide (PT-Cy) in Pediatric Patients With Acute Lymphoblastic Leukemia Group Paediatric Diseases Working Party (PDWP) 1st listed author Annalisa Ruggeri Journal Transplant Cell Ther.
2021 Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Mohamed A Kharfan-Dabaja Journal Bone Marrow Transplant.
2021 Autologous stem cell transplantation for post-transplant lymphoproliferative disorders after solid organ transplantation: a retrospective analysis from the Lymphoma Working Party of the EBMT Group Lymphoma Working Party (LWP) 1st listed author Toby A Eyre Journal Bone Marrow Transplant.
2021 Improved Outcomes of Haploidentical Hematopoietic Cell Transplantation with Total Body Irradiation-Based Myeloablative Conditioning in Acute Lymphoblastic Leukemia Group Acute Leukemia Working Party (ALWP) 1st listed author Bhagirathbhai Dholaria Journal Transplant Cell Ther.
2021 Second allogeneic haematopoietic cell transplantation using HLA-matched unrelated versus T-cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia Group Acute Leukemia Working Party (ALWP) 1st listed author Mohamed A Kharfan-Dabaja Journal Br J Haematol.
2021 Natural killer cell alloreactivity in HLA-haploidentical hematopoietic transplantation: a study on behalf of the CTIWP of the EBMT Group Cellular Therapy & Immunobiology Working Party (CTIWP) 1st listed author Loredana Ruggeri Journal Bone Marrow Transplant.